TerminatedNot Applicable

Real-World Evaluation of Eko Murmur Analysis Software in a Point of Care Setting

Stopped: Data collection complete

United States103 participantsStarted 2022-03-11

Plain-language summary

The purpose of this research is to evaluate the impact of Eko AI plus EMAS (Eko Murmur Analysis Software) on a clinician's referral decision in a real-world primary care setting. There is an additional objective of understanding patient outcomes when patients are referred for cardiology follow-up and/or echocardiogram.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient verbally consents to participation * Patient is willing to have heart sounds recorded with an electronic stethoscope * Patient is age 50 years or older Exclusion Criteria: * Patient is unwilling or unable to give verbal informed consent * Patients experiencing a known or suspected acute cardiac event * Patient is under the age of 50 years old

What they're measuring

Impact of EMAS on echocardiogram order rates

Timeframe: 01/17/2022 - 11/30/2023

Impact of EMAS on cardiologist consult order rates

Timeframe: 01/17/2022 - 11/30/2023

Impact of EMAS on provider decision-making

Timeframe: 01/17/2022 - 11/30/2023

Trial details

NCT IDNCT05176899

SponsorEko Devices, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-08-03

View on ClinicalTrials.gov More Murmur, Heart trials